Results 11 to 20 of about 8,808,149 (269)

Proton therapy in the treatment of hepatocellular carcinoma

open access: yesFrontiers in Oncology, 2022
Liver cancer represents one of the most common causes of death from cancer worldwide. Hepatocellular carcinoma (HCC) accounts for 90% of all primary liver cancers. Among local therapies, evidence regarding the use of radiation therapy is growing.
Francesco Dionisi   +8 more
doaj   +1 more source

SFPQ and NONO suppress RNA:DNA-hybrid-related telomere instability

open access: yesNature Communications, 2019
LncRNA TERRA forms RNA-DNA hybrids at telomere sites leading to telomere instability. Here the authors identify the RNA interacting factors NONO and SFPQ as proteins that interact with TERRA and telomere chromatin and reveal putative roles for these ...
Eleonora Petti   +8 more
doaj   +1 more source

Systemic Sclerosis and Idiopathic Portal Hypertension: Report of a Case and Review of the Literature

open access: yesLife, 2022
The presence of liver involvement in systemic sclerosis (SSc) is considered atypical, besides the possible coexistence of other autoimmune hepatic disorders.
Michele Colaci   +4 more
doaj   +1 more source

Møte i Styret for BIBSYS-konsortiet 19-02-2021 [PDF]

open access: yes, 2021
Saksdokumenter for møte i Styret for BIBSYS-konsortiet 19/02 2021Saksdokumenter for møte i Styret for BIBSYS-konsortiet 19/02 ...
Unit
core  

Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab

open access: yesScientific Reports, 2022
Body composition parameters (BCp) have been associated with outcome in different tumor types. However, their prognostic value in patients with HER2-positive metastatic breast cancer (BC) receiving first line treatment with dual anti-HER2 antibody ...
Michela Palleschi   +11 more
doaj   +1 more source

Radiopsy: a prospective observational study on quantitative multiparametric whole-body magnetic resonance imaging to discriminate between smoldering and multiple myeloma

open access: yesHaematologica
Not available.
Giacomo Feliciani   +24 more
doaj   +1 more source

Accelerated hypofractionated radiotherapy plus chemotherapy for inoperable locally advanced non-small-cell lung cancer: final results of a prospective phase-II trial with a long-term follow-up

open access: yesRadiation Oncology, 2019
Background Concurrent chemotherapy and radiation using conventional fractionation is the standard treatment for inoperable, locally advanced non-small-cell lung cancer (NSCLC).
Elisabetta Parisi   +12 more
doaj   +1 more source

Clinical research activities during COVID-19: the point of view of a promoter of academic clinical trials

open access: yesBMC Medical Research Methodology, 2021
Background During the COVID-19 emergency, IRST IRCCS, an Italian cancer research institute and promoter of no profit clinical studies, adapted its activities and procedures as per European and national guidelines to maintain a high standard of clinical ...
Linda Valmorri   +10 more
doaj   +1 more source

Robotic resection of a single adenoid cystic tumor liver metastasis using ICG fluorescence. A case report and literature review

open access: yesFrontiers in Surgery, 2023
Adenoid cystic carcinoma (AdCC) is a rare tumor that typically develops in the salivary glands and less frequently in other sites of the head and neck region. Only a few cases of resected metachronous liver metastases have been reported.
Alessio Pasquale   +6 more
doaj   +1 more source

A rare case report of relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type, treated with Epcoritamab: results obtained and lesson learned

open access: yesFrontiers in Oncology
Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type (PCDLBCL-LT), is a rare and aggressive subtype of primary cutaneous B-cell lymphoma, predominantly affecting elderly individuals. The disease presents with nodular or tumorous skin lesions, mainly
Alessandro Cafaro   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy